Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives
about
sameAs
Synthesis and Anti-Hepatitis B Virus and Anti-Hepatitis C Virus Activities of 7-Deazaneplanocin A Analogues in VitroCrystal structures ofMycobacterium tuberculosisS-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitorsVaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsDeterminants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cellsSynthesis and antiviral activity of 7-deazaneplanocin A against orthopoxviruses (vaccinia and cowpox virus).In search of a selective antiviral chemotherapy.Antivirals and antiviral strategies.Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.Inhibition of histone methyltransferase EZH2 ameliorates early acute renal allograft rejection in ratsA survey of antiviral drugs for bioweapons.The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.The discovery of antiviral agents: ten different compounds, ten different stories.Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.Curious discoveries in antiviral drug development: the role of serendipity.Historical perspectives in the development of antiviral agents against poxvirusesEmerging role of SETDB1 as a therapeutic target.Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent.Mycophenolic acid inhibits replication of Type 2 Winnipeg, a cerebrospinal fluid-derived reovirus isolate.Pharmacokinetics of the antiviral agent 3-deazaneplanocin A.Novel nucleosides with vinyl fluoride or vinyl bromide moiety as open-chain analogs of neplanocin A.John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.Down-regulation of S-adenosyl-L: -homocysteine hydrolase reveals a role of cytokinin in promoting transmethylation reactions.Strategies in the Design of Antiviral DrugsA guided tour through the antiviral drug fieldPoly(Hydroxy)Carboxylates as Selective Inhibitors of Cytomegalovirus and Herpes Simplex Virus Replication
P2860
Q27489125-EB47E5E8-3950-40DD-A479-BF99F233C81FQ27652285-AF440A10-0885-4B0E-9A7A-4BB52C482B06Q28362129-8594B88F-7D85-48ED-BCE6-A49EA1F3B07BQ33948015-76045BA7-161F-4C21-AE9C-63F21D76AA81Q34619655-4E617293-8B98-4626-9E4A-14F8B4A08F11Q34684802-A299433C-F301-4DC7-925A-BB0088090CE1Q35375912-96DD0F15-6C25-49BF-AF36-1B6B0CEF63B2Q35889586-F5A1E033-69AD-4F4B-99E8-B066EA70E3B1Q35917157-230595CE-7823-46D8-9AC7-8CA43A34CF61Q36175311-CFF64555-268F-4F17-A906-DEC98AE9DE38Q36295162-8DD5B5BA-1DD2-48F4-BE40-37F70F761C35Q37051959-5E04BD81-234E-4904-A0DA-CDEA77428698Q37148421-9C85AF91-779F-4A4A-8FFC-CDF957F58B8DQ37406126-801B4784-63F1-482A-86BB-45E4EA0706A1Q37622501-86B46023-372E-4D60-B631-D04E3F4BAB9DQ38366289-DCF6852B-87EE-4C0E-9E24-03A5C2F31ADCQ38617932-BF246599-12A1-43CE-846B-93C3DCB23861Q39079803-82D98E2E-627C-4507-A7DA-6DBF4F30689BQ39140111-F7D6EC9C-EF1D-46DE-B6BF-435861DE7C16Q40551606-1110860C-8F26-48E4-9276-994136D2DB47Q40591012-AD82CD44-D045-4B78-9478-7076BB30960FQ40669336-E47D7654-9CD2-4DB0-8976-EF0DF812B792Q42635990-8D31C210-DE5C-4BEF-93FB-3DCB0BEE352DQ43741912-CCDD8954-3E40-4886-8BEB-8F39E84AE65EQ44091038-50522BD6-712B-4B17-896B-8260AB4FCA24Q46694144-4F617CF5-0EC0-4371-BFE9-08079278B496Q56786281-9738F3A7-DF2D-4279-B1D2-6EEA44136945Q56786373-99AE7F88-AFB2-495C-9E20-82F820F4A147Q57241507-D67705ED-EE8A-4D29-9AB1-BA8AA817358A
P2860
Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives
description
1989 nî lūn-bûn
@nan
1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@ast
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@en
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@nl
type
label
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@ast
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@en
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@nl
prefLabel
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@ast
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@en
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@nl
P2093
P2860
P3181
P356
P1476
Broad-spectrum antiviral activ ...... , and their 5'-nor derivatives
@en
P2093
D R Borcherding
R T Borchardt
V E Marquez
P2860
P304
P3181
P356
10.1128/AAC.33.8.1291
P407
P577
1989-08-01T00:00:00Z